Why the study?
To systematically review changes in thrombomodulin expression after injury, its structural domain composition, mechanisms, and anticoagulant, anti-inflammatory, and antitumor effects to support potential clinical implications in various diseases.
Design
Systematic review
Authors
Loading...
rhsTM's anti-inflammatory and anti-tumor roles merit targeted trials; leaves open expanded indications beyond anticoagulation.
Key points are not available for this paper at this time.
Yang et al. (2025) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: